Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver F Bathe

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
BMC Cancer|January 6, 2018
A quantitative multimodal metabolomic assay for colorectal cancerFarshad Farshidfar, Karen A Kopciuk, Robert Hilsden, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 25, 2010
Feasibility of identifying pancreatic cancer based on serum metabolomicsOliver F Bathe, Rustem Shaykhutdinov, Karen Kopciuk, et al.
Vaccine|January 3, 2012
Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccineBrad S Thomas, Sandra Nishikawa, Kenichi Ito, et al.
British Journal of Cancer|August 26, 2016
A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomicsFarshad Farshidfar, Aalim M Weljie, Karen A Kopciuk, et al.
Genome Medicine|May 16, 2012
Serum metabolomic profile as a means to distinguish stage of colorectal cancerFarshad Farshidfar, Aalim M Weljie, Karen Kopciuk, et al.
Metabolites|January 19, 2017
Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography-Mass SpectrometryYarrow J McConnell, Farshad Farshidfar, Aalim M Weljie, et al.
Cancers|June 14, 2016
RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1Natalia Volodko, Mohamed Salla, Alaa Zare, et al.
Frontiers in Endocrinology|September 29, 2023
A clinically useful and biologically informative genomic classifier for papillary thyroid cancerSteven Craig, Cynthia Stretch, Farshad Farshidfar, et al.
European Radiology|May 2, 2021
Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancerEmmanuel Salinas-Miranda, Dominik Deniffel, Xin Dong, et al.
Oncotarget|January 14, 2022
Early detection of treatment futility in patients with metastatic colorectal cancerJodi I Rattner, Karen A Kopciuk, Hans J Vogel, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
BMC Cancer|January 6, 2018
A quantitative multimodal metabolomic assay for colorectal cancerFarshad Farshidfar, Karen A Kopciuk, Robert Hilsden, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 25, 2010
Feasibility of identifying pancreatic cancer based on serum metabolomicsOliver F Bathe, Rustem Shaykhutdinov, Karen Kopciuk, et al.
Vaccine|January 3, 2012
Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccineBrad S Thomas, Sandra Nishikawa, Kenichi Ito, et al.
British Journal of Cancer|August 26, 2016
A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomicsFarshad Farshidfar, Aalim M Weljie, Karen A Kopciuk, et al.
Genome Medicine|May 16, 2012
Serum metabolomic profile as a means to distinguish stage of colorectal cancerFarshad Farshidfar, Aalim M Weljie, Karen Kopciuk, et al.
Metabolites|January 19, 2017
Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography-Mass SpectrometryYarrow J McConnell, Farshad Farshidfar, Aalim M Weljie, et al.
Cancers|June 14, 2016
RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1Natalia Volodko, Mohamed Salla, Alaa Zare, et al.
Frontiers in Endocrinology|September 29, 2023
A clinically useful and biologically informative genomic classifier for papillary thyroid cancerSteven Craig, Cynthia Stretch, Farshad Farshidfar, et al.
European Radiology|May 2, 2021
Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancerEmmanuel Salinas-Miranda, Dominik Deniffel, Xin Dong, et al.
Oncotarget|January 14, 2022
Early detection of treatment futility in patients with metastatic colorectal cancerJodi I Rattner, Karen A Kopciuk, Hans J Vogel, et al.
Pageof 12